Medtech Insight’s Cardiovascular Catch-Up highlights recent news on cardiovascular tech innovations that you may have missed. Leonard Ganz, chief medical officer at Abbott’s cardiac rhythm management business, talked to Medtech Insight about the company’s new Assert-IQ insertable cardiac monitor, which offers long-term monitoring and remote programming to improve connectivity.
Abbott expects its new Assert-IQ insertable cardiac monitor (ICM) to improve remote arrhythmia management and complement its successful CardioMEMS implantable pressure sensor.
“Assert-IQ revolutionizes the diagnosis and treatment of people with heart rhythm disturbances,” Leonard Ganz, chief medical officer at Abbott’s cardiac rhythm management business, told Medtech Insight